Clinical Trials Directory

Trials / Completed

CompletedNCT04604002

Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types

Status
Completed
Phase
Study type
Observational
Enrollment
86 (actual)
Sponsor
Heidelberg Engineering GmbH · Industry
Sex
All
Age
22 Years
Healthy volunteers
Accepted

Summary

Assessment of image quality and clinical relevance of OCT Angiography at different speed/ART combinations

Detailed description

The objectives of this study are: 1.) Compare the image quality between the predicate scan types and the corresponding investigational scan types. 2\. Compare the visibility of key anatomical vascular structures between the predicate scan types and the corresponding investigational scan types. 3\. Assess the agreement in identification of vascular abnormalities between the predicate scan types and the corresponding investigational scan types, where agreement is assessed by the vascular abnormalities identified from the predicate scan types.

Conditions

Interventions

TypeNameDescription
DEVICEOCT AngiographyOCT Angiography offers clinicians a non-invasive three-dimensional visualization of vasculature in the retina and choroid. The visualization of perfused vasculature in a three-dimensional layout, offers clinicians an aid in the identification of retinal and choroidal pathologies such as retinal ischemia, microaneurysms, retinal neovascularization and choroidal neovascular membranes.
DEVICEColor Fundus PhotographyNon-contact white light photography
DEVICEOptical Coherence TomographyA non-contact test that uses light waves to take cross-sectional pictures of the retina

Timeline

Start date
2020-10-15
Primary completion
2022-01-04
Completion
2022-01-04
First posted
2020-10-27
Last updated
2024-02-28

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04604002. Inclusion in this directory is not an endorsement.